AxoGen, Inc. AXGN
43.39
0.07
0.16%
as of 25 Sep
- Market cap
- $2.5B
- P/E
- 0.0×
Follow AXGN
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
3.86 | 6.69 | 7.18 | 9.81 | |
P/FCF ratio |
402.65 | 0.00 | 223.17 | 378.46 | |
P/Operating CF |
257.36 | 496.12 | 1,092.16 | 341.19 | |
P/B ratio |
6.87 | 11.70 | 6.98 | 9.61 | |
Price to Tangible BV |
7.25 | 12.34 | 7.20 | 9.91 | |
EV/Sales |
3.99 | 6.79 | 6.83 | 9.44 | |
EV/EBITDA |
69.78 | 986.66 | 3,460.14 | 0.00 | |
EV/Operating CF |
131.72 | 1,883.41 | 104.54 | 157.54 | |
EV/FCF |
416.18 | (319.81) | 212.33 | 364.14 | |
Quick Ratio |
2.52 | 3.04 | 5.07 | 4.86 | |
Current Ratio |
4.09 | 5.11 | 7.10 | 6.60 | |
Net Debt/EBITDA |
6.49 | (3.36) | 129.83 | 23,830.25 | |
Debt/Assets |
30.30% | 30.51% | 7.13% | 5.93% | |
Debt/Equity |
0.54 | 0.52 | 0.08 | 0.07 | |
Asset Turnover |
1.05 | 1.06 | 0.98 | 0.98 | |
Operating CF/Net income |
4.55 | (0.23) | (0.08) | (4.76) | |
Capex/Depreciation |
(0.90) | (0.61) | (1.35) | (0.81) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
12.59% | 20.66% | 12.23% | 12.32% | |
Selling, General and Administrative Expense of Revenue |
60.78% | 69.79% | 67.53% | 63.45% | |
Intangible Assets out of Total Assets |
0.03 | 0.03 | 0.03 | 0.02 | |
Share Based Compensation of Revenue |
9.03% | 27.73% | 11.13% | 12.57% | |
Graham Net Nets |
0.02 | 0.02 | 0.08 | 0.06 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(0.25%) | (1.02%) | (1.92%) | (1.46%) | |
Free Cash Flow Yield |
0.25% | (0.32%) | 0.45% | 0.26% | |
Revenue per Share |
1.29 | 1.30 | 1.19 | 1.31 | |
Operating CF per Share |
0.07 | 0.07 | 0.03 | 0.14 | |
Capex per Share |
(0.04) | (0.04) | (0.06) | (0.03) | |
Free Cash Flow per Share |
0.03 | 0.02 | (0.03) | 0.10 | |
Cash per Share |
0.86 | 0.99 | 2.01 | 2.13 | |
Shareholders Equity per Share |
2.60 | 2.80 | 4.75 | 4.80 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.60 | 2.80 | 4.75 | 4.80 | |
Free Cash Flow |
1.36 | 1.08 | (1.40) | 5.47 | |
Working Capital |
86.45 | 96.87 | 158.70 | 170.00 | |
Capital Expenditures |
(1.86) | (1.96) | (2.96) | (1.75) | |
Net Current Asset Value |
18.86 | 27.58 | 140.03 | 151.77 | |
EV/EBIT |
217.60 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.03 | 0.03 | 0.05 | 0.03 | |
Net Profit Margin |
1.18% | (21.96%) | (31.87%) | (2.17%) | |
Price to Operating Income |
210.52 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
27.70 | 25.14 | 27.30 | 31.08 | |
Average Payables |
23.42 | 24.91 | 21.78 | 25.58 | |
Average Inventory |
34.97 | 37.78 | 40.79 | 42.04 | |
Average Assets |
204.19 | 212.71 | 242.83 | 255.16 | |
Average Common Equity |
110.11 | 116.38 | 175.09 | 184.27 |
Columns are period end dates